Dimensions
DimensionsDevanandan, Praveen and Puvvada, RanadheerChowdary and Muthukumar, VijeyAanandhi (2021) Lymphopenia as a marker for disease severity in COVID-19 patients: A metaanalysis. Asian Pacific Journal of Tropical Medicine, 13 (9). p. 426. ISSN 1995-7645
![[thumbnail of 131.pdf]](https://ir.vistas.ac.in/style/images/fileicons/archive.png)
Archive
131.pdf
Download (271kB)
Official URL: https://doi.org/10.4103/1995-7645.290588
Abstract
COVID-19 has become the global focus since December 2019[1]. Patients usually experience cough, fever and flu-like symptoms. Most patients also experience dyspnoea. Elevated procalcitonin, lymphopenia are observed in COVID-19 patients. Recently, a case series analysis has predicted that lymphopenia may be a very good prognostic marker for disease progression in COVID-19[2]
| Item Type: | Article |
|---|---|
| Subjects: | Pharmaceutics > Pharmaceutical Microbiology |
| Divisions: | Pharmaceutics |
| Depositing User: | Mr IR Admin |
| Date Deposited: | 19 Sep 2024 09:41 |
| Last Modified: | 19 Sep 2024 09:41 |
| URI: | https://ir.vistas.ac.in/id/eprint/6517 |
Actions (login required)
- View Item